These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling. Liu D, Huang Y, Bu D, Liu AD, Holmberg L, Jia Y, Tang C, Du J, Jin H. Cell Death Dis; 2014 May 22; 5(5):e1251. PubMed ID: 24853429 [Abstract] [Full Text] [Related]
5. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway. Zhu Q, Ni XQ, Lu WW, Zhang JS, Ren JL, Wu D, Chen Y, Zhang LS, Yu YR, Tang CS, Qi YF. Atherosclerosis; 2017 Nov 22; 266():212-222. PubMed ID: 29053988 [Abstract] [Full Text] [Related]
7. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol. Sun L, Zhao R, Zhang L, Zhang W, He G, Yang S, Song J, Du G. Biochem Pharmacol; 2016 Mar 01; 103():40-52. PubMed ID: 26807478 [Abstract] [Full Text] [Related]
8. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. Kim AS, Werlin EC, Kagaya H, Chen M, Wu B, Mottola G, Jan M, Conte MS. PLoS One; 2022 Mar 01; 17(2):e0264217. PubMed ID: 35226675 [Abstract] [Full Text] [Related]
10. 17Beta-estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Kappert K, Caglayan E, Huntgeburth M, Bäumer AT, Sparwel J, Uebel M, Rosenkranz S. Am J Physiol Heart Circ Physiol; 2006 Feb 01; 290(2):H538-46. PubMed ID: 16227346 [Abstract] [Full Text] [Related]
11. cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells. Simo-Cheyou ER, Youreva V, Srivastava AK. Can J Physiol Pharmacol; 2017 Aug 01; 95(8):928-937. PubMed ID: 28460186 [Abstract] [Full Text] [Related]
12. Inhibition of Egr1 expression underlies the anti-mitogenic effects of cAMP in vascular smooth muscle cells. Kimura TE, Duggirala A, Hindmarch CC, Hewer RC, Cui MZ, Newby AC, Bond M. J Mol Cell Cardiol; 2014 Jul 01; 72(100):9-19. PubMed ID: 24534707 [Abstract] [Full Text] [Related]
13. Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins. Begum N, Hockman S, Manganiello VC. J Biol Chem; 2011 Jul 22; 286(29):26238-49. PubMed ID: 21632535 [Abstract] [Full Text] [Related]